Analyst Ratings for Bicycle Therapeutics (BCYC)
BCYC Rating Summary
BCYC Price Target Summary
- Highest: $44.00 (Oppenheimer)
- Lowest: $11.00 (RBC Capital)
- Average: $19.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.80 (+281.5%)
* Over Last 12-Mos
Rating Score: 7.2 / 10
Percentile Rank: 77%
Avg. $ Target:
$19.80 (+281.5%)
* Over Last 12-Mos
Rating Score: 7.2 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/24/2025 | Truist Securities | Greg Renza | New Coverage | Hold (N/A) |
19.00 (N/A) |
6.32 (5.19) |
-17.88% | Details |
| 10/31/2025 | RBC Capital | Leonid Timashev | Downgrade | Sector Perform (Outperform) |
11.00 (27.00) |
8.18 (5.19) |
-36.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
